Search results for "neonatal"

showing 10 items of 581 documents

Intrauterine growth restriction and congenital malformations: a retrospective epidemiological study

2013

Background: Intrauterine growth restriction (IUGR) and small for gestational age (SGA) birth have been considered possible indicators of the presence of malformations. The aim of this study is to evaluate such relationships in a population of newborns, along with other epidemiological and auxological parameters, in particular the ponderal index (PI). Methods: We analyzed the birth data of 1093 infants, classified according to weight for gestational age as SGA, appropriate for gestational age (AGA) or large for gestational age (LGA). The prevalence of malformations was analyzed in relation to weight percentile at birth and SGA birth, maternal smoking, pregnancy diseases and PI. Results: Our …

MalePediatricsmedicine.medical_specialtyBirth weightPopulationIntrauterine growth restrictionGestational AgeSensitivity and SpecificityBody Mass IndexCongenital AbnormalitiesSettore MED/38 - Pediatria Generale E SpecialisticaWeight percentileNeonatal ScreeningPredictive Value of TestsPregnancyRisk FactorsPrevalenceMedicineBirth WeightHumanseducationSicilyreproductive and urinary physiologyRetrospective StudiesCongenital malformationsSGAPregnancyeducation.field_of_studyFetal Growth Retardationbusiness.industryObstetricsResearchInfant NewbornGestational agemedicine.diseaseBody Heightfemale genital diseases and pregnancy complicationsPonderal indexPredictive value of testsInfant Small for Gestational AgeSmall for gestational ageCongenital malformationFemalebusinessBody mass indexItalian Journal of Pediatrics
researchProduct

Intrauterine growth pattern and birthweight discordance in twin pregnancies: a retrospective study

2013

Background: Twins, compared to singletons, have an increased risk of perinatal mortality and morbidity, due mainly to a higher prevalence of preterm birth and low birthweight. Intrauterine growth restriction (IUGR) is also common and can affect one or both fetuses. In some cases, however, one twin is much smaller than the other (growth discordance). Usually, high birthweight discordance is associated with increased perinatal morbidity. The aim of this study is to describe the epidemiological features of a population of twins at birth, with particular reference to the interpretation and clinical effects of birthweight discordance. Methods: We evaluated retrospectively the clinical features o…

MalePediatricsmedicine.medical_specialtyBirth weightPopulationTwinsNeonatal anemiaIntrauterine growth restrictionGestational AgeInfant Newborn DiseasesWeight percentileSettore MED/38 - Pediatria Generale E SpecialisticaPregnancyRisk FactorsInfant MortalityDiseases in TwinsBirth WeightHumansMedicineeducationreproductive and urinary physiologyTwin PregnancyRetrospective StudiesSGAPregnancyeducation.field_of_studyFetal Growth Retardationbusiness.industryObstetricsResearchInfant NewbornTwinGestational ageBirthweight discordancemedicine.diseaseTwin studyItalyPremature birthPregnancy TwinPremature BirthFemaleMorbiditybusinessFollow-Up StudiesItalian Journal of Pediatrics
researchProduct

Prevalence and risk factors for sensorineural hearing loss: Western Sicily overview.

2013

The objective of this work was to evaluate the prevalence of sensorineural hearing loss (SNHL) and distribution of the main risk factors associated to it focusing on their role in the development of deafness and their interaction. We performed a global audiological assessment (through TEOAE, tympanometry and ABR) in 508 infants at risk studying the main risk factors reported by Joint Committee on Infant Hearing (2007). Fifty-one infants (10.03 %) were diagnosed with SNHL (45 bilateral and 6 unilateral) with a mean hearing threshold of 87.39 ± 28.25 dB HL; family history of hearing impairment (HI) and TORCH infections indicated independent significant risk factors (P < 0.00001 and P = 0.0…

MalePediatricsmedicine.medical_specialtyCraniofacial abnormalityHearing lossHearing Loss SensorineuralAudiologySettore MED/38 - Pediatria Generale E SpecialisticaNeonatal ScreeningRisk Factorsotorhinolaryngologic diseasesEvoked Potentials Auditory Brain StemPrevalenceMedicineHumansFamily historySicilyAbsolute threshold of hearingInfants at risk Neonatal hearing screening Sensorineural hearing loss NICU infantsmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)IncidenceInfant NewbornInfantGeneral MedicineTympanometrymedicine.diseaseConductive hearing lossSettore MED/32 - AudiologiaSettore MED/31 - OtorinolaringoiatriaOtorhinolaryngologySensorineural hearing lossFemalemedicine.symptombusinessEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
researchProduct

Ketogenic diet for infants with epilepsy: A literature review.

2020

Abstract The ketogenic diet (KD) is an established, nonpharmacological treatment for drug-resistant epilepsy (DRE). Actually, KD and its variants have been shown to be elective and resolute for patients with glucose transporter type 1 (GLUT1) deficiency. The aim of this review was to study the use of KD and its variants in infancy, including the neonatal age, and demonstrate the safety and efficacy of this treatment in patients with the age of 0–23 months affected by DRE already subjected to pharmacological approach attempts. A literature search was conducted using PubMed as the medical database source. We used the age limit of 0–23 months, and we considered only articles published between …

MalePediatricsmedicine.medical_specialtyDrug Resistant EpilepsyKetogenicmedicine.medical_treatmentDrug-resistant epilepsyDrug-resistant epilepsy Epilepsy Glucose transporter type 1 deficiency Infant Ketogenic diet Diet Ketogenic Disease Management Drug Resistant Epilepsy Epilepsy Female Glucose Transporter Type 1 Humans Infant. Infant Newborn. Male Seizures Treatment OutcomeNeonatal ageNewborn. MaleAge limitlaw.invention03 medical and health sciencesBehavioral NeuroscienceEpilepsy0302 clinical medicineRandomized controlled triallawSeizuresmedicineGlucose transporter type 1 deficiencyHumans030212 general & internal medicineProspective cohort studyGlucose Transporter Type 1Epilepsybusiness.industryInfant NewbornDisease ManagementInfantRetrospective cohort studyKetogenic dietInfant. InfantDrug Resistant Epilepsymedicine.diseaseDietTreatment OutcomeNeurologyFemaleNeurology (clinical)businessDiet Ketogenic030217 neurology & neurosurgeryKetogenic dietEpilepsybehavior : EB
researchProduct

Clinical approach to the analysis of causes of death in the first two years of life of very‐low‐birthweight infants in a multicentre setting

1997

Mortality in the first 2 years of 634 very-low-birthweight infants admitted to eight neonatal intensive care units in Italy, and the factors associated with the net probability of death from each cause, were studied by means of the Cox proportional hazard model. A clinical classification of the causes of death was used. Overall mortality was 33.7% (intercentre range 12.6-52.9%). The highest cause-specific mortality rates were observed for respiratory problems, intra-ventricular haemorrhage (IVH) and infections (14.5%, 6.3% and 5.7% respectively). The leading causes of death were respiratory problems and IVH in the first week of life, infections from the second week up to the end of the firs…

MalePediatricsmedicine.medical_specialtyEpidemiologyInfant Premature DiseasesCongenital AbnormalitiesRisk FactorsCause of DeathIntensive Care Units NeonatalIntensive careOdds RatiomedicineHumansInfant Very Low Birth WeightLife TablesProspective StudiesProspective cohort studyProportional Hazards ModelsCause of deathProportional hazards modelbusiness.industryMortality rateInfant NewbornGestational ageOdds ratiomedicine.diseaseItalyBronchopulmonary dysplasiaMultivariate AnalysisPediatrics Perinatology and Child HealthFemalebusinessPaediatric and Perinatal Epidemiology
researchProduct

Predictive Factors of Abdominal Compartment Syndrome in Neonatal Age

2014

In the pediatric population, abdominal compartment syndrome (ACS) is a known complication of abdominal wall defect repair. However, there are only few reports on ACS in newborns and only a proposal of critical intra-abdominal pressure value (IAP) in term newborns, absent in preterm newborns. Although the prevalent clinical sign is tense abdominal distension, it may be difficult to distinguish ACS from pathologies that will not require decompression. The purpose of this study was to identify predictors for ACS and therefore morbidity or mortality indicators. We reviewed newborns presenting with tense abdominal distension and end organ failure. Anamnestic, clinical, laboratory, and instrument…

MalePediatricsmedicine.medical_specialtyNeonatal intensive care unitAbdominal compartment syndromePopulationGestational AgeAbdominal wallSettore MED/38 - Pediatria Generale E SpecialisticaIntubation IntratrachealHumansMedicineLactic AcideducationAbdominal Compartment Syndrome Predictive Factors in Neonatal AgeRetrospective Studieseducation.field_of_studybusiness.industryIncidenceAbdominal wall defectAbdominal WallInfant NewbornObstetrics and GynecologyGestational ageAbdominal distensionmedicine.diseaseRespiration ArtificialSurgerymedicine.anatomical_structureCase-Control StudiesPediatrics Perinatology and Child HealthApgar ScoreFemaleIntra-Abdominal HypertensionIntra-Abdominal Hypertensionmedicine.symptombusinessAmerican Journal of Perinatology
researchProduct

Hypoproteinemia on the first day of life and adverse outcome in very preterm infants admitted to the neonatal intensive care unit

2012

International audience; OBJECTIVE: We aimed to investigate the relationship between day-1 hypoproteinemia and severe adverse outcome (SAO) in very preterm infants admitted to the neonatal intensive care unit (NICU). STUDY DESIGN: Retrospective study of all patients born from 24 to 31 weeks gestation and cared for in our NICU over an 8-year period. Infants were excluded if the serum protein value on the first day of life was not available. RESULT: A total of 913 patients were included. In all, 14.6% presented with SAO (death or severe neurological injury on cranial ultrasound). Hypoproteinemia (total protein level \textless40 g l(-1)) on day 1 of life occurred in 19.5 % of all patients. The …

MalePediatricsmedicine.medical_specialtyNeonatal intensive care unitAdverse outcomesLeukomalacia PeriventricularBirth weightDay of lifeMEDLINE[ SDV.MHEP.PED ] Life Sciences [q-bio]/Human health and pathology/PediatricsDiseasesInfant Premature Diseases03 medical and health sciencesHypoproteinemia0302 clinical medicineIntensive Care Units Neonatal030225 pediatricsNeonatalMedicineBirth WeightHumans030212 general & internal medicinePrematureCerebral HemorrhageHypoproteinemia[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsPeriventricularbusiness.industryInfant NewbornObstetrics and GynecologyInfantBlood Proteinsmedicine.diseaseNewbornInfant newborn3. Good healthVery pretermIntensive Care UnitsPediatrics Perinatology and Child HealthFemalebusinessInfant PrematureLeukomalacia
researchProduct

Methemoglobinemia Associated with Late-Onset Neonatal Sepsis: A Single-Center Experience

2019

Objective Methemoglobinemia (MetHb) is a rare congenital or acquired cause of infantile cyanosis. We examined the role of MetHb in a neonatal intensive care unit (NICU). Study Design A retrospective observational study was conducted reviewing blood gas analyses of hospitalized newborns over a 2-year period. MetHb-positive patients (MetHb >1.8%) were matched with a control group for gestational age, weight, disease, and illness severity at admission. Maternal, neonatal, clinical, and laboratory parameters were collected and analyzed in both groups. Results MetHb incidence was 6%. The mean MetHb in the case group was 7.2%, and the first positive samples were observed at a mean of 22 days …

MalePediatricsmedicine.medical_specialtyNeonatal intensive care unitAnemiacyanosiGestational AgeDiagnosis DifferentialSepsis03 medical and health sciencesEnteral Nutrition0302 clinical medicinenewbornRisk FactorsIntensive Care Units NeonatalHumansMedicineHypoxiaRetrospective StudiesCyanosis030219 obstetrics & reproductive medicineNeonatal sepsisbusiness.industryIncidenceIncidence (epidemiology)Infant NewbornObstetrics and GynecologyGestational ageRetrospective cohort studyPrognosismedicine.diseaseanemiaParenteral nutritionCase-Control StudiesPediatrics Perinatology and Child Healthobservational studyFemaleBlood Gas AnalysisNeonatal SepsisMethemoglobinemiabusinessAmerican Journal of Perinatology
researchProduct

Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease

2014

Abstract Objective: Bronchopulmonary dysplasia (BPD) or chronic lung disease is one of the principal causes of mortality and morbidity in preterm infants. Early identification of infants at the greater risk of developing BPD may allow a targeted approach for reducing disease severity and complications. The trigger cause of the disease comprehends the impairment of the alveolar development and the increased angiogenesis. Nevertheless, the molecular pathways characterizing the disease are still unclear. Therefore, the use of the metabolomics technique, due to the capability of identifying instantaneous metabolic perturbation, might help to recognize metabolic patterns associated with the cond…

MalePediatricsmedicine.medical_specialtyNeonatal intensive care unitBirth weightUrinary systemProton Magnetic Resonance SpectroscopymetaboliteGestational AgeDiseaseMetabolomicsSettore MED/38 - Pediatria Generale E SpecialisticaIntensive Care Units NeonatalmedicineHumansInfant Very Low Birth WeightMetabolomicsmultivariate statistical analysisbusiness.industryInfant Newborn1H-NMRObstetrics and GynecologyGestational agemedicine.diseaseBronchopulmonary dysplasiaLow birth weightBronchopulmonary dysplasiaPediatrics Perinatology and Child HealthMetabolomeFemalemedicine.symptombusinessBiomarkersInfant Prematuremetabolomic
researchProduct

Short-Term Neurodevelopmental Outcome in Term Neonates Treated with Phenobarbital versus Levetiracetam: A Single-Center Experience

2019

Background. Phenobarbital (PB) has been traditionally used as the first-line treatment for neonatal seizures. More recently, levetiracetam (LEV) has been increasingly used as a promising newer antiepileptic medication for treatment of seizures in neonates. Objectives. The aim of our study was to compare the effect of PB vs. LEV on short-term neurodevelopmental outcome in infants treated for neonatal seizures. Method. This randomized, one-blind prospective study was conducted on term neonates admitted to the Neonatal Intensive Care Unit of S. Bambino Hospital, University Hospital “Policlinico-Vittorio Emanuele,” Catania, Italy, from February 2016 to February 2018. Thirty term neonates with s…

MalePediatricsmedicine.medical_specialtyNeonatal intensive care unitLevetiracetamArticle Subjectneonatal seizures levetiracetam neurodevelopmental outcomemedicine.medical_treatmentneonatal seizuresNeurological examinationNeurosciences. Biological psychiatry. NeuropsychiatrySingle CenterNO03 medical and health sciences0302 clinical medicineSeizures030225 pediatricsmedicineHumansProspective StudiesProspective cohort studymedicine.diagnostic_testbusiness.industryInfant NewbornAnticonvulsants Treatment Outcome Infant Newborn Italy Levetiracetam Neurodevelopmental Disorders Phenobarbital SeizuresInfantPhenobarbital; neonatal seizures; LevetiracetamGeneral MedicineTerm neonatesNewbornNeuropsychology and Physiological PsychologyAnticonvulsantTreatment OutcomeNeurologyItalyNeurodevelopmental DisordersPhenobarbitalClinical StudyPhenobarbitalFemaleAnticonvulsantsNeurology (clinical)Levetiracetambusiness030217 neurology & neurosurgerymedicine.drugRC321-571Behavioural Neurology
researchProduct